Furthermore, EZH2 has been linked to epigenetic inactivation of WNT5A, a proposed tumor suppressor, during TGF-ß-induced epithelial-mesenchymal transition in an in vitro model of CRC [61]. The gene discussed is EZH2; the disease is colorectal carcinoma.